Shionogi’s treatment is said to be effective even after 48 hours from the emergence of symptoms, unlike the “Tamiflu” influenza medication, which must be administered within 48 hours.
The company, which acquired the development and sales rights to the medication from a US-based firm, claims that the new medicine has proved to be effective against the highly virulent H5N1 type of influenza, or so-called bird flu.